Trial
NCT03711279
A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Collaborators
—
Condition
Sarcoma
Intervention
SHR-1210 plus Apatinib
Why stopped
Sponsor R \& D Strategy Adjustment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-29